Gland B2B Business Model and Growth Strategy
Promoted by Shanghai Fosun Pharma
Shanghai Fosun Pharma is Global Pharmaceutical Major with Extensive Pharmaceutical
Manufacturing, Distribution and R&D Expertise Globally
FOSUN PHARMA
复星医药
Fosun Pharma is a Global pharmaceutical major, whose shares are listed on the Shanghai Stock
Exchange and the Stock Exchange of Hong Kong Limited (1)
Relationship with Shanghai Fosun Pharma provides widened market access opportunities arising from
its own continuing internationalization
Benefitted from Shanghai Fosun Pharma's established presence in China and Africa, both of which we
consider to be key growth markets for injectables
Continue Strategic Alignment with Shanghai Fosun Pharma to Increase Market Reach
Leverage existing
infrastructure and global
presence to access new
markets, including China
and Africa
Benefit from regulatory
know-how to navigate the
rapidly evolving healthcare
landscape in China
32
32
(1) Market cap of US$ 15.0 bn as of March 31, 2021.
Benefit from bargaining
power and scale to procure
raw materials & equipment
from China
Access extensive sales,
logistics and distribution
network to enable market
penetration in China
Leverage ability to access
key markets to provide
coverage for a portfolio of
products
GLANDView entire presentation